|
|
TriPharm Services announces creation of pharmaceutical manufacturing center |
TriPharm Services, a new contract development and manufacturing organization (CDMO), is commissioning a new specialized manufacturing operation utiliz...
|
|
|
Shionogi and Hsiri to develop mycobacterial disease therapies |
Japanese pharmaceutical firm Shionogi has signed a licence agreement with Hsiri Therapeutics for the discovery and development of therapies for non...
|
|